According to Vision Research Reports, the global heel incision devices market size is expected to surpass at US$ 225 million by 2027 and is projected to expand at a CAGR of 3.1% from 2021 to 2027.
Blood samples from infants can be obtained from either an indwelling catheter or a heel puncture. Puncturing a newborn's heel for blood collection is a crucial step in the process of detecting potentially fatal, congenital diseases. Heel incision devices are safe, gentle, and effective to collect blood from babies. Heel incision device provides a precise incision for adequate blood sampling with less re-sticking. Heel incision devices are available for newborn, preemie, micro-preemie, and toddler. North America dominated the global heel incision devices market in 2019. The trend is anticipated to continue during the forecast period. Mandatory newborn screening under the Newborn Screening Saves Lives Act of 2007 across North America propels the demand for heel incision devices.
Mandatory Newborn Testing Policy Adopted in Several Countries to Drive Heel Incision Devices Market
Premature babies, especially those born very early, often have complicated medical issues. Typically, complications of prematurity vary; however, earlier the baby is born, the higher the risk of complications. Therefore, dozens of new tests are presently available, which can offer insights into the health condition of newborns. High birth rate of preterm babies leads to complications and even to death of babies within one month of birth, which is a global concern, especially in underdeveloped and developing countries of Africa and South Asia. Consequently, several countries, such as the U.S., Australia, Germany, and the U.K., have introduced numerous health policies under which newborn screening is mandatory, which, in turn, propels the heel incision devices market.
Innovative Devices Promote Fast Healing and Less Bruising in Babies
Manufacturers in the heel incision devices market are increasing their production capacities for lancets that eliminate the need for heel warming. The elimination of heel warming is being associated with time and cost efficiency in hospitals, since the nursing time is reduced and the hospital financial expenditure is also lowered. This has led to increased productivity levels in healthcare facilities, as additional minutes spent on heel warming results in adding up of substantial cost during the blood collection procedure. Thus, innovative heel incision devices are lowering the expenditure to purchase heel warmers.
Companies in the heel incision devices market are innovating in lancets that produce a steady consistent arc motion, which promotes fast healing and less bruising. There is a growing demand for devices that deliver gentle skin incision. Latest heel incision devices are eliminating the need for repeat sticks in order to collect a large enough blood sample.
Small Players Increase R&D Activities to Address Needs of Complex Medical Conditions
Established players in the heel incision devices market are gaining a competitive edge over emerging market players, since babies are inherently fragile and many infants have complex medical conditions. Since emerging players and startups lack the right amount of capital expenditure, leading market players are outpacing smaller players. Hence, emerging players must invest in R&D activities and collaborate with think tanks from universities and international healthcare organizations to identify drawbacks in existing heel incision devices. Companies in the heel incision devices market should research about alternate methods that are replacing lancets since the market is projected to register a sluggish CAGR of ~3% during the forecast period.
Startups in the market for heel incision devices should innovate in lancets that are designed for specialized and delicate care. They should adopt standardized length and depth measures to carefully control incision in babies.
Demand for High-quality Blood Samples Triggers Innovations in Single-use Devices
Companies in the heel incision devices market are increasing the availability of single-use safety heel sticks. For instance, the Novaplus MediHeel incision device by Medicore is designed for infants and neonatal patients to meet single-use applications. Manufacturers are strengthening their distribution chains via e-Commerce. For instance, the Lancet Tenderfoot Infant device is being made available online in order to increase product uptake. Next-gen incision devices are emerging as an alternative to puncture in the heel of infants. The growing demand for high-quality blood sample has triggered the expansion of the heel incision devices market.
Improved mechanisms in devices are delivering greater incision depth control above the nerve fibers, resulting in less pain in infants. Manufacturers are increasing efforts to enhance user comfort by introducing ergonomic designs in devices. They are offering comfortable grip for permanent retraction of the blade, catering to user safety.
Products for Newborns to Dominate Heel Incision Devices Market
In terms of product type, the global heel incision devices market has been classified into micro-preemie, preemie, newborn, and infant. Doctors prefer to screen newborns within the first 1 to 2 days after birth to diagnosis diseases, as it takes that long for abnormal levels to show up in the blood, and this is likely to fuel the segment.
Hospitals & Specialty Clinics to be Highly Attractive End User
In terms of end user, the heel incision devices market has been divided into hospitals & specialty clinics, ambulatory surgical centers, and others. The high preference for hospitals & nursing homes due to availability of all levels of treatment, reimbursement facilities, and rise in awareness about different treatment support provided in hospitals are key factors driving the segment.
North America to Dominate Heel Incision Devices Market
The global heel incision devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global heel incision devices market in 2019, followed by Europe. North America accounted for a major share of the global heel incision devices market in 2019, primarily due to well-established healthcare infrastructure that enables proper diagnosis. Moreover, a rise in awareness about newborn screening in the U.S. drives the demand for heel incision devices.
Competition Landscape
The global heel incision devices market is fragmented in terms of number of players. Key players in the global surgical equipment market include BD, Owen Mumford Ltd., Cardinal Health, Smiths Medical, Clinical Innovations, LLC, MediCore, Vitrex Medical A/S, NSP Medicals, and Torvan Medical Inc.
Market Segmentation
By Product Type
By End User
By Region
Scope of the Report
VRR’s report on the global heel incision devices market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2020 to 2030. The report provides revenue of the global heel incision devices market for the period 2018–2030, considering 2020 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global heel incision devices market during the forecast period.
The report has been prepared after extensive primary and secondary researches. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players, product type literature, annual reports, press releases, and relevant documents to understand the global heel incision devices market.
Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global heel incision devices market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global heel incision devices market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global heel incision devices market.
The report delves into the competition landscape of the global heel incision devices market. Key players operating in the global heel incision devices market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global heel incision devices market that have been profiled in this report.
Key Questions Answered in Heel Incision Devices Market Report
Research Methodology
A unique research methodology has been utilized by VRR to conduct comprehensive research on the growth of the global heel incision devices market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary researches, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary sources referred to by analysts during the product type of the global heel incision devices market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product type portfolio managers, and market intelligence managers who contributed to VRR’s study on the heel incision devices market as primary research sources.
These primary and secondary research sources have provided exclusive information during interviews, which serves as a validation from the heel incision devices market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global heel incision devices market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching VRR’s estimates on future prospects of the global heel incision devices market more reliably and accurately.
Table of Contents
1.Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Heel Incision Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Market Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunity
5. Key Insights
5.1. List of Major Hospitals & Maternity Centers
5.2. Pricing Analysis
5.3. Global Heel Incision Devices: Key Industry Events
5.4. COVID-19 Impact Analysis
5.5. Regulatory Scenario
6. Global Heel Incision Devices Market Analysis and Forecast, by Product Type
6.1. Key Findings / Developments
6.2. Introduction & Definition
6.3. Global Heel Incision Devices Market Value Forecast, by Product Type, 2018–2027
6.3.1. Micro-preemie
6.3.2. Preemie
6.3.3. Newborn
6.3.4. Infant
6.4. Global Heel Incision Devices Market Attractiveness Analysis, by Product Type
7. Global Heel Incision Devices Market Analysis and Forecast, by End-user
7.1. Key Findings / Developments
7.2. Introduction & Definition
7.3. Global Heel Incision Devices Market Value Forecast, by End-user, 2018–2027
7.3.1. Hospitals & Specialty Clinics
7.3.2. Ambulatory Surgical Centers
7.3.3. Others
7.4. Global Heel Incision Devices Market Attractiveness Analysis, by End-user
8. Global Heel Incision Devices Market Analysis and Forecast, by Region
8.1. Geographical Representation
8.2. Global Heel Incision Devices Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global Heel Incision Devices Market Attractiveness Analysis, by Region
9. North America Heel Incision Devices Market Analysis and Forecast
9.1. North America Heel Incision Devices Market Value Forecast, by Country, 2018–2027
9.1.1. U.S.
9.1.2. Canada
9.2. North America Heel Incision Devices Market Value Forecast, by Product Type, 2018–2027
9.3. North America Heel Incision Devices Market Value Forecast, by End-user, 2018–2027
9.4. North America Heel Incision Devices Market Attractiveness Analysis, 2020–2027
9.4.1. By Country
9.4.2. By Product Type
9.4.3. By End-user
10. Europe Heel Incision Devices Market Analysis and Forecast
10.1. Europe Heel Incision Devices Market Value Forecast, by Country/Sub-region, 2018–2027
10.1.1. Germany
10.1.2. France
10.1.3. U.K.
10.1.4. Spain
10.1.5. Italy
10.1.6. Rest of Europe
10.2. Europe Heel Incision Devices Market Value Forecast, by Product Type, 2018–2027
10.3. Europe Heel Incision Devices Market Value Forecast, by End-user, 2018–2027
10.4. Europe Heel Incision Devices Market Attractiveness Analysis, 2020–2027
10.4.1. By Country/Sub-region
10.4.2. By Product Type
10.4.3. By End-user
11. Asia Pacific Heel Incision Devices Market Analysis and Forecast
11.1. Asia Pacific Heel Incision Devices Market Value Forecast, by Country/Sub-region, 2018–2027
11.1.1. Japan
11.1.2. China
11.1.3. India
11.1.4. Australia & New Zealand
11.1.5. Rest of Asia Pacific
11.2. Asia Pacific Heel Incision Devices Market Value Forecast, by Product Type, 2018–2027
11.3. Asia Pacific Heel Incision Devices Market Value Forecast, by End-user, 2018–2027
11.4. Asia Pacific Heel Incision Devices Market Attractiveness Analysis, 2020–2027
11.4.1. By Country/Sub-region
11.4.2. By Product Type
11.4.3. By End-user
12. Latin America Heel Incision Devices Market Analysis and Forecast
12.1. Latin America Heel Incision Devices Market Value Forecast, by Country/Sub-region, 2018–2027
12.1.1. Brazil
12.1.2. Mexico
12.1.3. Rest of Latin America
12.2. Latin America Heel Incision Devices Market Value Forecast, by Product Type, 2018–2027
12.3. Latin America Heel Incision Devices Market Value Forecast, by End-user, 2018–2027
12.4. Latin America Heel Incision Devices Market Attractiveness Analysis, 2020–2027
12.4.1. By Country/Sub-region
12.4.2. By Product Type
12.4.3. By End-user
13. Middle East & Africa Heel Incision Devices Market Analysis and Forecast
13.1. Middle East & Africa Heel Incision Devices Market Value Forecast, by Country/Sub-region, 2018–2027
13.1.1. GCC Countries
13.1.2. South Africa
13.1.3. Rest of Middle East & Africa
13.2. Middle East & Africa Heel Incision Devices Market Value Forecast, by Product Type, 2018–2027
13.3. Middle East & Africa Heel Incision Devices Market Value Forecast, by End-user, 2018–2027
13.4. Middle East & Africa Heel Incision Devices Market Attractiveness Analysis, 2020–2027
13.4.1. By Country/Sub-region
13.4.2. By Product Type
13.4.3. By End-user s
14. Competitive Landscape
14.1. Market Share Analysis, by Company, 2019
14.2. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)
14.2.1. BD
14.2.1.1. Company Details
14.2.1.2. Company Description
14.2.1.3. Business Overview
14.2.1.4. SWOT Analysis
14.2.1.5. Financial Analysis
14.2.1.6. Strategic Overview
14.2.2. Owen Mumford Ltd.
14.2.2.1. Company Details
14.2.2.2. Company Description
14.2.2.3. Business Overview
14.2.2.4. SWOT Analysis
14.2.2.5. Strategic Overview
14.2.3. Cardinal Health
14.2.3.1. Company Details
14.2.3.2. Company Description
14.2.3.3. Business Overview
14.2.3.4. SWOT Analysis
14.2.3.5. Strategic Overview
14.2.4. Smiths Medical
14.2.4.1. Company Details
14.2.4.2. Company Description
14.2.4.3. Business Overview
14.2.4.4. SWOT Analysis
14.2.4.5. Strategic Overview
14.2.5. Clinical Innovations, LLC.
14.2.5.1. Company Details
14.2.5.2. Company Description
14.2.5.3. Business Overview
14.2.5.4. SWOT Analysis
14.2.5.5. Financial Analysis
14.2.5.6. Strategic Overview
14.2.6. MediCore
14.2.6.1. Company Details
14.2.6.2. Company Description
14.2.6.3. Business Overview
14.2.6.4. SWOT Analysis
14.2.6.5. Financial Analysis
14.2.6.6. Strategic Overview
14.2.7. Vitrex Medical A/S
14.2.7.1. Company Details
14.2.7.2. Company Description
14.2.7.3. Business Overview
14.2.7.4. SWOT Analysis
14.2.7.5. Financial Analysis
14.2.7.6. Strategic Overview
14.2.8. NSP Medicals
14.2.8.1. Company Details
14.2.8.2. Company Description
14.2.8.3. Business Overview
14.2.8.4. SWOT Analysis
14.2.8.5. Financial Analysis
14.2.8.6. Strategic Overview
14.2.9. Torvan Medical Inc.
14.2.9.1. Company Details
14.2.9.2. Company Description
14.2.9.3. Business Overview
14.2.9.4. SWOT Analysis
14.2.9.5. Strategic Overview